All the news articles and press releases in one place.

Search
Date / Time Source Ticker Company Sector Market Cap Announcement
02Mar18 13:30 RNS FARN:LON, AV:LON Aviva plc, Faron Pharmaceuticals Oy Various Various Holding(s) in Company
02Mar18 13:25 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Holding(s) in Company
01Mar18 12:42 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Holdings in Company
01Mar18 12:41 RNS FARN:LON, LGEN:LON Faron Pharmaceuticals Oy, Legal & General Group Plc Various Various Holdings in Company
26Feb18 13:37 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Issue of Equity
21Feb18 15:31 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Results of Placing & Issue of Equity
16Feb18 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Proposed Placing to raise up to £15m
29Jan18 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m FDA grants Fast Track Designation for Traumakine®
24Jan18 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m FDA approval of Faron's Traumakine® IND
19Dec17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m INFORAAA trial receives recommendation from IDMC
11Dec17 07:32 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Recruitment completed in Traumakine INTEREST Trial
06Dec17 18:06 RNS FARN:LON, LGEN:LON Faron Pharmaceuticals Oy, Legal & General Group Plc Various Various Holding(s) in Company
01Dec17 14:55 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Holdings in Company
24Nov17 10:23 RNS FARN:LON, LGEN:LON Faron Pharmaceuticals Oy, Legal & General Group Plc Various Various Holding(s) in Company
21Nov17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Grant of options
20Nov17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Change of Adviser
16Oct17 09:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Holding(s) in Company
13Oct17 09:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Director/PDMR Shareholding
11Oct17 14:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Issue of Equity & PDMR Shareholding
09Oct17 16:30 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Result of Placing & Subscription & Issue of Equity
05Oct17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Proposed Placing and Subscription
02Oct17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Traumakine Receives PIM Designation from MHRA
11Sep17 15:19 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Directors Dealings
06Sep17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Interim Results
04Sep17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m FDA advises Faron to proceed directly to BLA
04Aug17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Update on INTEREST Phase III Study from IDMC
28Jul17 09:34 RNS FARN:LON, AV:LON Aviva plc, Faron Pharmaceuticals Oy Various Various Holding(s) in Company
10Jul17 16:51 RNS FARN:LON, AV:LON Aviva plc, Faron Pharmaceuticals Oy Various Various Holding(s) in Company
10Jul17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Notice of Results
16Jun17 14:43 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Director/PDMR Shareholding
01Jun17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Exercise of Warrants and Options
30May17 14:06 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Holdings in Company
22May17 11:31 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Director/PDMR Shareholding
22May17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Director/PDMR Shareholding
18May17 09:20 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Director/PDMR Shareholding
16May17 12:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Result of AGM
08May17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Update on INTEREST Phase III Study from IDMC
27Apr17 17:57 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Exercise of Warrants
26Apr17 12:32 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Director's dealings
21Apr17 17:56 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Director/PDMR Shareholding
19Apr17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Proposed Board Changes
19Apr17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Notice of Annual General Meeting
18Apr17 16:17 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Purchase of Shares
18Apr17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Collaboration with Birmingham University
13Apr17 13:43 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Purchase of Shares
04Apr17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Director/PDMR Shareholding
29Mar17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Final Results 2016
27Mar17 09:23 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Holding(s) in Company
07Mar17 10:54 RNS FARN:LON, LGEN:LON Faron Pharmaceuticals Oy, Legal & General Group Plc Various Various Holding(s) in Company
07Mar17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Notice of Full Year Results
03Mar17 11:02 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Holding(s) in Company
01Mar17 11:35 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Result of Placing & Subscription & Issue of Equity
28Feb17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Proposed Placing and Subscription
20Feb17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m First Patient Recruited in Phase II RAAA Study
09Feb17 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Faron update for 2017
09Dec16 13:05 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Notification of Major Interest in Shares
09Dec16 13:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Notification of Major Interest in Shares
05Dec16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m PDMR Shareholding
21Nov16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Grant of options
31Oct16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m New Application Accepted by Finnish Patent Office
24Oct16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m First patient recruited in Japanese Ph III trial
07Oct16 13:41 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Notification of Major Interest in Shares
06Oct16 10:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Notification of Major Interest in Shares
05Oct16 17:10 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Notification of Major Interest in Shares
26Sep16 15:59 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Director Dealing
21Sep16 11:27 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Raises £8.0 M through a Placing and Subscription
20Sep16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Proposed Placing & Subscription to raise £8M
05Sep16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Interim Results for six months ended 30 June 2016
10Aug16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Faron Pharmaceuticals Notice of Interim Results
14Jun16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Faron Provides Update at R&D Day
13Jun16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Faron Licenses Traumakine Rights to Pharmbio Korea
26May16 10:53 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Faron Result of Annual General Meeting
26May16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Faron Expands R&D Strategy for Clevegen
13May16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Faron Pharmaceuticals Ltd to host an R&D Day
04May16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Notice of AGM
03May16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Faron Appoints New Medical Director
22Apr16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Faron Appoints Panmure Gordon as Joint Broker
19Apr16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Faron Files Two New Patents to Protect Clevegen
10Mar16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Annual Results for the year ended 31 December 2015
01Mar16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Faron files patent application for Traumakine
10Feb16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Notice of Preliminary Results
07Jan16 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Top-line results from Japanese study of Traumakine
29Dec15 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m First Patient recruited in Phase III ARDS Study
21Dec15 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Faron Awarded ?1.5 million Tekes Funding
30Nov15 07:00 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Key Publication in Journal of Immunology
17Nov15 07:30 RNS FARN:LON Faron Pharmaceuticals Oy Health £94.6m Admission to AIM and first day of dealings
Date / Time Source Company % Chg
02Mar18 13:30 RNS Aviva plc, Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
02Mar18 13:25 RNS Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
01Mar18 12:42 RNS Faron Pharmaceuticals Oy 0.00%
Holdings in Company
01Mar18 12:41 RNS Faron Pharmaceuticals Oy, Legal & General Group Plc 0.00%
Holdings in Company
26Feb18 13:37 RNS Faron Pharmaceuticals Oy 0.00%
Issue of Equity
21Feb18 15:31 RNS Faron Pharmaceuticals Oy 0.00%
Results of Placing & Issue of Equity
16Feb18 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Proposed Placing to raise up to £15m
29Jan18 07:00 RNS Faron Pharmaceuticals Oy 0.00%
FDA grants Fast Track Designation for Traumakine®
24Jan18 07:00 RNS Faron Pharmaceuticals Oy 0.00%
FDA approval of Faron's Traumakine® IND
19Dec17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
INFORAAA trial receives recommendation from IDMC
11Dec17 07:32 RNS Faron Pharmaceuticals Oy 0.00%
Recruitment completed in Traumakine INTEREST Trial
06Dec17 18:06 RNS Faron Pharmaceuticals Oy, Legal & General Group Plc 0.00%
Holding(s) in Company
01Dec17 14:55 RNS Faron Pharmaceuticals Oy 0.00%
Holdings in Company
24Nov17 10:23 RNS Faron Pharmaceuticals Oy, Legal & General Group Plc 0.00%
Holding(s) in Company
21Nov17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Grant of options
20Nov17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Change of Adviser
16Oct17 09:00 RNS Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
13Oct17 09:00 RNS Faron Pharmaceuticals Oy 0.00%
Director/PDMR Shareholding
11Oct17 14:00 RNS Faron Pharmaceuticals Oy 0.00%
Issue of Equity & PDMR Shareholding
09Oct17 16:30 RNS Faron Pharmaceuticals Oy 0.00%
Result of Placing & Subscription & Issue of Equity
05Oct17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Proposed Placing and Subscription
02Oct17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Traumakine Receives PIM Designation from MHRA
11Sep17 15:19 RNS Faron Pharmaceuticals Oy 0.00%
Directors Dealings
06Sep17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Interim Results
04Sep17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
FDA advises Faron to proceed directly to BLA
04Aug17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Update on INTEREST Phase III Study from IDMC
28Jul17 09:34 RNS Aviva plc, Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
10Jul17 16:51 RNS Aviva plc, Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
10Jul17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Notice of Results
16Jun17 14:43 RNS Faron Pharmaceuticals Oy 0.00%
Director/PDMR Shareholding
01Jun17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Exercise of Warrants and Options
30May17 14:06 RNS Faron Pharmaceuticals Oy 0.00%
Holdings in Company
22May17 11:31 RNS Faron Pharmaceuticals Oy 0.00%
Director/PDMR Shareholding
22May17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Director/PDMR Shareholding
18May17 09:20 RNS Faron Pharmaceuticals Oy 0.00%
Director/PDMR Shareholding
16May17 12:00 RNS Faron Pharmaceuticals Oy 0.00%
Result of AGM
08May17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Update on INTEREST Phase III Study from IDMC
27Apr17 17:57 RNS Faron Pharmaceuticals Oy 0.00%
Exercise of Warrants
26Apr17 12:32 RNS Faron Pharmaceuticals Oy 0.00%
Director's dealings
21Apr17 17:56 RNS Faron Pharmaceuticals Oy 0.00%
Director/PDMR Shareholding
19Apr17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Proposed Board Changes
19Apr17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Notice of Annual General Meeting
18Apr17 16:17 RNS Faron Pharmaceuticals Oy 0.00%
Purchase of Shares
18Apr17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Collaboration with Birmingham University
13Apr17 13:43 RNS Faron Pharmaceuticals Oy 0.00%
Purchase of Shares
04Apr17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Director/PDMR Shareholding
29Mar17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Final Results 2016
27Mar17 09:23 RNS Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
07Mar17 10:54 RNS Faron Pharmaceuticals Oy, Legal & General Group Plc 0.00%
Holding(s) in Company
07Mar17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Notice of Full Year Results
03Mar17 11:02 RNS Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
01Mar17 11:35 RNS Faron Pharmaceuticals Oy 0.00%
Result of Placing & Subscription & Issue of Equity
28Feb17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Proposed Placing and Subscription
20Feb17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
First Patient Recruited in Phase II RAAA Study
09Feb17 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron update for 2017
09Dec16 13:05 RNS Faron Pharmaceuticals Oy 0.00%
Notification of Major Interest in Shares
09Dec16 13:00 RNS Faron Pharmaceuticals Oy 0.00%
Notification of Major Interest in Shares
05Dec16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
PDMR Shareholding
21Nov16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Grant of options
31Oct16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
New Application Accepted by Finnish Patent Office
24Oct16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
First patient recruited in Japanese Ph III trial
07Oct16 13:41 RNS Faron Pharmaceuticals Oy 0.00%
Notification of Major Interest in Shares
06Oct16 10:00 RNS Faron Pharmaceuticals Oy 0.00%
Notification of Major Interest in Shares
05Oct16 17:10 RNS Faron Pharmaceuticals Oy 0.00%
Notification of Major Interest in Shares
26Sep16 15:59 RNS Faron Pharmaceuticals Oy 0.00%
Director Dealing
21Sep16 11:27 RNS Faron Pharmaceuticals Oy 0.00%
Raises £8.0 M through a Placing and Subscription
20Sep16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Proposed Placing & Subscription to raise £8M
05Sep16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Interim Results for six months ended 30 June 2016
10Aug16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharmaceuticals Notice of Interim Results
14Jun16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Provides Update at R&D Day
13Jun16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Licenses Traumakine Rights to Pharmbio Korea
26May16 10:53 RNS Faron Pharmaceuticals Oy 0.00%
Faron Result of Annual General Meeting
26May16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Expands R&D Strategy for Clevegen
13May16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Pharmaceuticals Ltd to host an R&D Day
04May16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Notice of AGM
03May16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Appoints New Medical Director
22Apr16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Appoints Panmure Gordon as Joint Broker
19Apr16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Files Two New Patents to Protect Clevegen
10Mar16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Annual Results for the year ended 31 December 2015
01Mar16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron files patent application for Traumakine
10Feb16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Notice of Preliminary Results
07Jan16 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Top-line results from Japanese study of Traumakine
29Dec15 07:00 RNS Faron Pharmaceuticals Oy 0.00%
First Patient recruited in Phase III ARDS Study
21Dec15 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Faron Awarded ?1.5 million Tekes Funding
30Nov15 07:00 RNS Faron Pharmaceuticals Oy 0.00%
Key Publication in Journal of Immunology
17Nov15 07:30 RNS Faron Pharmaceuticals Oy 0.00%
Admission to AIM and first day of dealings
Date / Time Company % Chg
02Mar18 13:30 AV. LSE,FARN LSE 0.00%
Holding(s) in Company
02Mar18 13:25 Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
01Mar18 12:42 Faron Pharmaceuticals Oy 0.00%
Holdings in Company
01Mar18 12:41 FARN LSE,LGEN LSE 0.00%
Holdings in Company
26Feb18 13:37 Faron Pharmaceuticals Oy 0.00%
Issue of Equity
21Feb18 15:31 Faron Pharmaceuticals Oy 0.00%
Results of Placing & Issue of Equity
16Feb18 07:00 Faron Pharmaceuticals Oy 0.00%
Proposed Placing to raise up to £15m
29Jan18 07:00 Faron Pharmaceuticals Oy 0.00%
FDA grants Fast Track Designation for Traumakine®
24Jan18 07:00 Faron Pharmaceuticals Oy 0.00%
FDA approval of Faron's Traumakine® IND
19Dec17 07:00 Faron Pharmaceuticals Oy 0.00%
INFORAAA trial receives recommendation from IDMC
11Dec17 07:32 Faron Pharmaceuticals Oy 0.00%
Recruitment completed in Traumakine INTEREST Trial
06Dec17 18:06 FARN LSE,LGEN LSE 0.00%
Holding(s) in Company
01Dec17 14:55 Faron Pharmaceuticals Oy 0.00%
Holdings in Company
24Nov17 10:23 FARN LSE,LGEN LSE 0.00%
Holding(s) in Company
21Nov17 07:00 Faron Pharmaceuticals Oy 0.00%
Grant of options
20Nov17 07:00 Faron Pharmaceuticals Oy 0.00%
Change of Adviser
16Oct17 09:00 Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
13Oct17 09:00 Faron Pharmaceuticals Oy 0.00%
Director/PDMR Shareholding
11Oct17 14:00 Faron Pharmaceuticals Oy 0.00%
Issue of Equity & PDMR Shareholding
09Oct17 16:30 Faron Pharmaceuticals Oy 0.00%
Result of Placing & Subscription & Issue of Equity
05Oct17 07:00 Faron Pharmaceuticals Oy 0.00%
Proposed Placing and Subscription
02Oct17 07:00 Faron Pharmaceuticals Oy 0.00%
Traumakine Receives PIM Designation from MHRA
11Sep17 15:19 Faron Pharmaceuticals Oy 0.00%
Directors Dealings
06Sep17 07:00 Faron Pharmaceuticals Oy 0.00%
Interim Results
04Sep17 07:00 Faron Pharmaceuticals Oy 0.00%
FDA advises Faron to proceed directly to BLA
04Aug17 07:00 Faron Pharmaceuticals Oy 0.00%
Update on INTEREST Phase III Study from IDMC
28Jul17 09:34 AV. LSE,FARN LSE 0.00%
Holding(s) in Company
10Jul17 16:51 AV. LSE,FARN LSE 0.00%
Holding(s) in Company
10Jul17 07:00 Faron Pharmaceuticals Oy 0.00%
Notice of Results
16Jun17 14:43 Faron Pharmaceuticals Oy 0.00%
Director/PDMR Shareholding
01Jun17 07:00 Faron Pharmaceuticals Oy 0.00%
Exercise of Warrants and Options
30May17 14:06 Faron Pharmaceuticals Oy 0.00%
Holdings in Company
22May17 11:31 Faron Pharmaceuticals Oy 0.00%
Director/PDMR Shareholding
22May17 07:00 Faron Pharmaceuticals Oy 0.00%
Director/PDMR Shareholding
18May17 09:20 Faron Pharmaceuticals Oy 0.00%
Director/PDMR Shareholding
16May17 12:00 Faron Pharmaceuticals Oy 0.00%
Result of AGM
08May17 07:00 Faron Pharmaceuticals Oy 0.00%
Update on INTEREST Phase III Study from IDMC
27Apr17 17:57 Faron Pharmaceuticals Oy 0.00%
Exercise of Warrants
26Apr17 12:32 Faron Pharmaceuticals Oy 0.00%
Director's dealings
21Apr17 17:56 Faron Pharmaceuticals Oy 0.00%
Director/PDMR Shareholding
19Apr17 07:00 Faron Pharmaceuticals Oy 0.00%
Proposed Board Changes
19Apr17 07:00 Faron Pharmaceuticals Oy 0.00%
Notice of Annual General Meeting
18Apr17 16:17 Faron Pharmaceuticals Oy 0.00%
Purchase of Shares
18Apr17 07:00 Faron Pharmaceuticals Oy 0.00%
Collaboration with Birmingham University
13Apr17 13:43 Faron Pharmaceuticals Oy 0.00%
Purchase of Shares
04Apr17 07:00 Faron Pharmaceuticals Oy 0.00%
Director/PDMR Shareholding
29Mar17 07:00 Faron Pharmaceuticals Oy 0.00%
Final Results 2016
27Mar17 09:23 Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
07Mar17 10:54 FARN LSE,LGEN LSE 0.00%
Holding(s) in Company
07Mar17 07:00 Faron Pharmaceuticals Oy 0.00%
Notice of Full Year Results
03Mar17 11:02 Faron Pharmaceuticals Oy 0.00%
Holding(s) in Company
01Mar17 11:35 Faron Pharmaceuticals Oy 0.00%
Result of Placing & Subscription & Issue of Equity
28Feb17 07:00 Faron Pharmaceuticals Oy 0.00%
Proposed Placing and Subscription
20Feb17 07:00 Faron Pharmaceuticals Oy 0.00%
First Patient Recruited in Phase II RAAA Study
09Feb17 07:00 Faron Pharmaceuticals Oy 0.00%
Faron update for 2017
09Dec16 13:05 Faron Pharmaceuticals Oy 0.00%
Notification of Major Interest in Shares
09Dec16 13:00 Faron Pharmaceuticals Oy 0.00%
Notification of Major Interest in Shares
05Dec16 07:00 Faron Pharmaceuticals Oy 0.00%
PDMR Shareholding
21Nov16 07:00 Faron Pharmaceuticals Oy 0.00%
Grant of options
31Oct16 07:00 Faron Pharmaceuticals Oy 0.00%
New Application Accepted by Finnish Patent Office
24Oct16 07:00 Faron Pharmaceuticals Oy 0.00%
First patient recruited in Japanese Ph III trial
07Oct16 13:41 Faron Pharmaceuticals Oy 0.00%
Notification of Major Interest in Shares
06Oct16 10:00 Faron Pharmaceuticals Oy 0.00%
Notification of Major Interest in Shares
05Oct16 17:10 Faron Pharmaceuticals Oy 0.00%
Notification of Major Interest in Shares
26Sep16 15:59 Faron Pharmaceuticals Oy 0.00%
Director Dealing
21Sep16 11:27 Faron Pharmaceuticals Oy 0.00%
Raises £8.0 M through a Placing and Subscription
20Sep16 07:00 Faron Pharmaceuticals Oy 0.00%
Proposed Placing & Subscription to raise £8M
05Sep16 07:00 Faron Pharmaceuticals Oy 0.00%
Interim Results for six months ended 30 June 2016
10Aug16 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharmaceuticals Notice of Interim Results
14Jun16 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Provides Update at R&D Day
13Jun16 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Licenses Traumakine Rights to Pharmbio Korea
26May16 10:53 Faron Pharmaceuticals Oy 0.00%
Faron Result of Annual General Meeting
26May16 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Expands R&D Strategy for Clevegen
13May16 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Pharmaceuticals Ltd to host an R&D Day
04May16 07:00 Faron Pharmaceuticals Oy 0.00%
Notice of AGM
03May16 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Appoints New Medical Director
22Apr16 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Appoints Panmure Gordon as Joint Broker
19Apr16 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Files Two New Patents to Protect Clevegen
10Mar16 07:00 Faron Pharmaceuticals Oy 0.00%
Annual Results for the year ended 31 December 2015
01Mar16 07:00 Faron Pharmaceuticals Oy 0.00%
Faron files patent application for Traumakine
10Feb16 07:00 Faron Pharmaceuticals Oy 0.00%
Notice of Preliminary Results
07Jan16 07:00 Faron Pharmaceuticals Oy 0.00%
Top-line results from Japanese study of Traumakine
29Dec15 07:00 Faron Pharmaceuticals Oy 0.00%
First Patient recruited in Phase III ARDS Study
21Dec15 07:00 Faron Pharmaceuticals Oy 0.00%
Faron Awarded ?1.5 million Tekes Funding
30Nov15 07:00 Faron Pharmaceuticals Oy 0.00%
Key Publication in Journal of Immunology
17Nov15 07:30 Faron Pharmaceuticals Oy 0.00%
Admission to AIM and first day of dealings